BOSTON CLINICAL TRIALS, LLC – Trademark Portfolio
Entity Type: 03
BOSTON CLINICAL TRIALS, LLC holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 5 filings in this category. Currently, 5 trademarks are registered. Notable registered marks include ACTIVMED RESEARCH, BOSTON CLINICAL TRIALS, ACTIVMATTERS OF THE BRAIN, ACTIVMATTERS OF THE BRAIN, INC., and ALLCUTIS RESEARCH, INC. CENTER FOR UNDERSTANDING THERAPEUTICS IN SKIN. The owner is based in Lake Mary, FL.
615 Crescent Executive Court
Suite 120
Lake Mary, FL 32746
Showing of trademarks Trademarks
Trademark Classifications
BOSTON CLINICAL TRIALS, LLC's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does BOSTON CLINICAL TRIALS, LLC have?
BOSTON CLINICAL TRIALS, LLC has 5 U.S. trademarks filed with the USPTO. Of these, 5 registered.
What trademark classes does BOSTON CLINICAL TRIALS, LLC file in?
BOSTON CLINICAL TRIALS, LLC files trademarks across 1 Nice Classification class. The most active classes are Class 42 (Computer & Scientific). Class 42 covers scientific and technological services; industrial analysis and research services.
What are BOSTON CLINICAL TRIALS, LLC's most well-known trademarks?
BOSTON CLINICAL TRIALS, LLC's registered trademark portfolio includes well-known marks such as ACTIVMED RESEARCH, BOSTON CLINICAL TRIALS, ACTIVMATTERS OF THE BRAIN, ACTIVMATTERS OF THE BRAIN, INC., and ALLCUTIS RESEARCH, INC. CENTER FOR UNDERSTANDING THERAPEUTICS IN SKIN. These are among 5 currently registered trademarks in the portfolio.
What is BOSTON CLINICAL TRIALS, LLC's trademark registration success rate?
BOSTON CLINICAL TRIALS, LLC has a 100% trademark registration rate, with 5 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.